Investigation of microfluidic hepatocyte and hepatic progenitor cell cultures in vitro by Goli, Vidya M.
 
 
 
 
Investigation of Microfluidic Hepatocyte and Hepatic 
Progenitor Cell Cultures In Vitro 
 
 
 
Vidya Goli 
 
 
 
A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Master of Science in the 
Department of Biomedical Engineering. 
 
 
 
 
 
 
Chapel Hill 
2007 
 
 
 
 
 
   Approved by 
 
 
                                                         
                                                          Advisor:  Professor Glenn M. Walker, Ph.D 
 
 
       
                                                         Reader:  Professor David A. Gerber, M.D. 
 
 
                                                         
                                                         Reader:  Professor Lola M. Reid, Ph.D. 
 
 ii 
 
 
 
 
Abstract 
 
Vidya M. Goli 
Investigation of Microfluidic Hepatocyte and Hepatic Progenitor Cell 
Cultures In Vitro. 
 
(Under the guidance of Glenn M. Walker, Ph.D)  
  
 The in vitro culture of liver cells has applications in extracorporeal bioreactors, 
generation of grafts for transplantation, and drug screening.  It was postulated that 
hepatic cells could be cultured within a microfluidic environment.  A series of 
microchannels of varied width was tested with hepatic progenitor cells (HPCs) and 
showed maintained viability and a measurable level of albumin.  Then HepG2 
hepatocarcinoma cells were tested in a “Spheroid Chamber” design to attempt to 
encase the cells and maintain cell viability.  Another device consisting of a channel 
layer and a well layer was then tested, resulting in successful seeding of the device 
but without maintained cell viability.  Then viability and albumin production were 
tested in a series of channels, showing albumin fluorescence and maintained 
viability.  In conclusion, we were able to show that HPC and HepG2 viability and 
hepatocellular behavior can be maintained in a microfluidic environment. 
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1 Introduction 
1.1 Rationale and Goals for the Project 
 
 Current high-throughput hepatic culture systems used for screening drug 
candidates lack the complexity of the in vivo tissue environment, which limits their 
ability to accurately predict candidate efficacy.  Recently, advances in the field of 
microscale tissue engineering have demonstrated the potential for culturing tissue 
for high-throughput assays in academic, pharmaceutical, and biotechnological 
applications.  Hepatic tissue regeneration in vitro could address the need for 
improved drug candidate screening and provide a potential source of implantable 
liver tissue.  Replacing the current two-dimensional hepatic culture systems with 
microscale three-dimensional systems could increase the precision of therapeutic 
readouts and enable early drug candidate validation at the tissue level in a cost-
efficient setting. 
 We envision our microfluidic devices eventually being used to screen for the 
efficacy of drug candidates on arrays of microscale hepatic tissue cultures. In this 
project hepatic progenitor cells (HPCs) and hepatocarcinoma HepG2 cells were 
cultured in both microchannels and microwells to observe the effect of these cell 
culture environments on the cells. The primary goal was to develop a device that is 
optimized for hepatocyte cell culture.  
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The hypothesis tested is that hepatic progenitor cells and HepG2 cells can remain 
viable and maintain hepatocellular function in microfluidic devices.  
 
The microfluidic devices provided useful information on HPC and HepG2 viability, 
differentiation, maturation, and proliferation in the microenvironment. The 
microfluidic devices developed allowed us to investigate how hepatic progenitor cells 
and HepG2 cells behave when cultured in a microenvironment that more faithfully 
mimics in vivo conditions than current high-throughput culture systems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Background 
 
2.1 Liver Culture Approaches 
 
 Liver cell culture in vitro has many potential applications.  These include 
extracorporeal liver support, engineering of grafts for transplantation, drug screening 
in vitro, and research on hepatocellular behavior.  A variety of liver cell culture 
methods have been developed to promote retention of hepatic function under in vitro 
conditions.[1]  Various microscale cell culture bioreactor designs exist in addition to 
macroscale cell culture bioreactor designs. 
2.1.1 Cell Culture on Scaffolds 
  
 Although the classical static method for liver cell culture consists of the 
uncoated plastic tissue culture dish, synthetic and hybrid biodegradable scaffoldings 
are in development for the purpose of in vitro maintenance and expansion of cells as 
well as in vivo transplantation of the cells. Natural degradable materials, e.g. 
collagen and laminin, have also been used in tissue engineering to enhance cell 
attachment, with the advantage of close compatibility with the extracellular matrix 
(ECM) environment found in the liver.  However they often lack mechanical integrity, 
may be immunogenic, and are often limited in supply. Therefore various 
biodegradable scaffoldings are in development, and these are used to coat surfaces 
including polystyrene, polyurethane, and cross-linked dextran.  The biodegradable 
scaffoldings most used are made from the poly ( α-hydroxy acid) family of polymers, 
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including poly(glycolic acid), poly(lactic acid), poly(D,L-lactide-co-glycolide) 
copolymer, and their modified derivatives.  Hybrid polymers are also in development 
and these are intended to solve the issues of the interaction between seeded cells 
and degradable scaffolds and the host response to the tissue engineered construct.  
These hybrid devices generally are designed to combine the biocompatibility of 
natural biopolymers with the desirable physical properties of synthetic polymers.[2] 
2.1.2 In Vitro Three-Dimensional Bioreactors 
  
 The types of three-dimensional culture systems in development include 
methods for spheroid culture, cell culture on biodegradable microcarriers kept in 
suspension, cell encapsulation, and hollow-fiber bioreactors.   
 For the culture of spheroids, hepatocytes have been cultured primarily either 
on tissue culture dishes and placed on a rotary shaker at a constant speed or 
cultured on a nonadherent substratum in static culture.  Spinner flasks or 
Erlenmeyer flasks have also been used when large-scale spheroid formation was 
necessary.  In addition, novel methods including the combination of the static and 
shaking methods, such as the use of poly(2-hydroxyethylmethacrylate (PHEMA)-
coated six well plates on a rotary shaker, have been described.  This method, when 
done at 90 rpm, is advantageous as it generates spheroids of less than 250 µm 
diameter, thus avoiding the decreased oxygen and nutrient diffusion that occurs with 
necrotic centers that are generated with spheroids greater than 250-300 µm in 
diameter. 
 The method of culturing cells on biodegradable microcarriers kept in 
suspension is another method that has been developed for the three-dimensional 
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culture of liver cells.  The use of porous PLGA beads as biodegradable microcarriers 
has been demonstrated. With this method, the beads are commonly first coated with 
collagen prior to addition of the cells for cell attachment.[2] 
 A method has also been described for the encapsulation of hepatic progenitor 
cells in alginate beads.  This method sought to use electrostatic encapsulation to 
generate an ex vivo environment for murine hepatic progenitor cells (HPCs).  In vitro 
analysis of the encapsulated beads demonstrated extended periods of viability and 
function based on albumin production, urea metabolism, and glycogen storage.  This 
study demonstrated that HPC encapsulation fosters the differentiation of HPCs into 
functional cells while maintaining their viability in long-term culture.[3] 
 Hollow fiber bioreactors are another commonly used type of bioreactor for 
liver cell culture.  Hollow fiber bioreactors are perfusion vessels comprising semi-
permeable fibers and composed of various polymers.  Hollow fiber bioreactors have 
been used in numerous bioartificial liver studies.[4-12] 
2.1.3 Microfluidic Bioreactors 
 
 Miniaturization of bioreactors to the microscale offers many advantages.  
These include high throughput, cost effectiveness, portability, and lowered cell 
numbers and reagent volumes.  In addition, the culture of cells at the microscale 
introduces the cells to a set of physical phenomena (discussed in Section 2.2.1) that 
may allow for a more in vivo-like environment.  Following are examples of existing 
microfluidic bioreactors for liver cell culture. 
 An in vitro model of liver zonation has been developed.  Allen et al.[13,14] 
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developed a polycarbonate-on-glass-slide parallel-plate perfused hepatocyte 
bioreactor that imposes physiologic oxygen gradients for an in vitro model of 
zonation and tested the bioreactor with a co-culture of primary rat hepatocytes and 
non-parenchymal cells.  The location of cells in the liver determines their response to 
a toxic insult.  Specifically, hepatocytes are distributed along the sinusoid in 
subpopulations into zones 1 to 3.  As a result a toxic insult generates different 
responses in different zones.  An in vitro hepatocyte bioreactor that represents liver 
zonation may provide a more accurate gauge of physiological hepatocytic responses 
to toxic insult by allowing for a measure of zonal hepatotoxicity.  To control the 
oxygen gradients used to model liver zonation, Allen et al. used mathematical 
modeling and experimental validation.  Experimental validation was observed in 
regional heterogeneity mimicking the distribution in the zonated liver, of CYP2B and 
CYP3A in co-cultures exposed to the oxygen gradients.  Then, zonal hepatotoxicity 
was confirmed by perfusion of the co-cultures with acetaminophen (APAP) for 24 
hours, which resulted in maximal cell death in the low oxygen outlet region similar to 
centrilobular necrotic patterns observed in vivo.  The device could allow for the study 
of other zonation-dependent hepatocellular behavior.   
 Leclerc et al. have developed a multi-layer microfluidic poly-dimethylsiloxane 
(PDMS) bioreactor for the large-scale culture of hepatocytes, with larger cell 
numbers and cell densities.[15] Large-scale hepatocyte culture might allow for more 
physiological hepatic function in vitro.  The device consists of ten stacked PDMS 
layers comprising four cell culture chambers and an oxygen chamber in the middle 
of the ten stacked layers.  To show that cellular activity was maintained in the 
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bioreactor, glucose consumption and albumin production were measured, and 
showed a gradual increase and saturation throughout the culture.  The oxygen 
chamber was found to generate longer and healthier cultures.  The cell density used 
in the bioreactor was 3-4 x 107 cells/cm3, on the same order as typical macroscale 
bioreactors.  Leclerc et al. conclude that the device could be a scalable method to 
realize the microfluidic bioreactor for large-scale cultures. Leclerc et al. have also 
constructed biodegradable tissue engineering scaffolds, with a photosensitive 
biodegradable polymer.[16,17] 
 Another feature added to microfluidic hepatocyte bioreactors is a membrane for 
cell attachment.[18]  Two types of PDMS bioreactors were fabricated, one with a 
commercially available polyester membrane and one with a PDMS membrane with 5 
µm x 5 µm hole sizes.  The membrane was used to mimic the relative surface area 
between blood perfusion and hepatocytes seen in vivo.  The microbioreactors with 
the PDMS membranes were shown to express greater albumin secretion than the 
polyester membrane as well as static cultures in tissue-culture-treated dishes and in 
cultures in inserts with the same polyester membranes.  Ammonia removal was also 
shown to be seven times greater in perfused cultures compared to static cultures.   
 Because co-cultivation of parenchymal and mesenchymal cells has been 
widely utilized as a paradigm for the study of cell-cell interactions in vitro and 
because co-cultures of two cell types provide more functional tissue constructs for 
use in therapeutic or investigational applications, Bhatia et al. have developed 
bioreactors in which co-cultures of primary rat hepatocytes and murine 3T3-J2 
fibroblasts were cultured in order to investigate the role of increasing fibroblast 
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density on hepatic function.[19]  Randomly distributed co-cultures were performed, 
and microfabrication was also used to pattern the cell populations by patterning 
collagen onto the substrate, allowing for the isolation of fibroblast number as an 
independent variable in hepatic function.  Collagen-modified borosilicate wafers 
were used for all the co-cultures.  To hold constant the homotypic interactions, the 
hepatocyte patterns used were similar in all conditions, and the region of contact 
between the cell populations was also held constant.  Synthetic and metabolic 
markers of liver-specific function were measured, and the data suggested that 
fibroblast number is a factor in modulation of hepatocellular response through 
homotypic fibroblast interactions.  Information on the interplay between the two cell 
types could allow for the formation of more functional model tissues in vitro or 
functional tissue for implantation. 
 A silicon microbioreactor has also been developed for hepatocyte cell 
culture.[1, 20] Deep reactive ion etching (DRIE) of silicon wafers was used to pattern 
an array of through-holes with cell-adhesive walls.  The sidewalls of the through-
holes were made cell-adhesive due to the fluoropolymer remaining on the sidewalls 
because of the SF6 etch followed by passivation in C4F8 involved in the DRIE 
process.  The silicon scaffolds were placed in a reactor housing with a filter and 
support for the silicon wafer with the housing designed to deliver a continuous 
perfusate across the top of the array and through the three-dimensional tissue mass 
in each channel.  Reactor dimensions were constructed to allow for estimated values 
of cellular oxygen uptake rates and also to allow for fluid shear stress at or below a 
physiological range (<2 dyne/cm2).  To test the reactor primary rat hepatocytes were 
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seeded and cultured for up to 2 weeks, and it was found that cells seeded into the 
through-holes rearranged extensively to form tissue like structures and remained 
viable throughout the culture period.  It was also observed that preaggregation of the 
cells into spheroidal structures prior to seeding improved the morphogenesis of 
tissue structure and viability.  In situ imaging of tissue structure and function using 
two-photon microscopy was also demonstrated. 
 A microchannel flat-plate bioreactor has also been developed to study the 
effects of oxygenation and flow on the viability and function of rat hepatocytes and 
3T3-J2 fibroblasts in co-culture.[21, 22]   The bioreactor, made of polycarbonate 
sheets, was made with and without an internal membrane oxygenator, to study the 
effect of oxygenation on cell viability and function.  In addition a range of channel 
heights and flow rates was used to study the effect of varied lower wall shear 
stresses on hepatocyte function as measured by albumin and urea synthesis rates.  
The oxygenated bioreactor was found to perform better than the one without the 
oxygenator, showing stable albumin and urea synthesis rates for 10 days of 
perfusion.  In addition, lower wall shear stresses (0.01 to 0.33 dyne/cm2) were found 
to genearate 2.6- and 1.9-fold greater albumin and urea synthesis rates than higher 
wall shear stresses (5 to 21 dyne/cm2). 
 An array of microfluidic wells has also been developed for the purpose of 
culturing primary mammalian hepatocytes.[23] Each well supported a 
micropatterned coculture of primary rat hepatocytes in coculture with 3T3-J2 
fibroblasts.  Each of the wells was continuously perfused with medium and oxygen 
via separate channels.  The hepatocytes in the array were shown to be capable of 
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continuous, steady-state albumin synthesis. 
 Biodegradable polymers have also been used for creating microfluidic tissue 
engineering scaffolds.[24]  Poly(glycerol sebacate) scaffolds were used to create two 
types of tissue engineering scaffolds, termed “vascular” and “hepatocyte” constructs.  
The first exhibited constant maximum shear stress within each channel of the device 
with the purpose of imitating vasculature.  The second allowed for high perfusion 
rates while also allowing for high levels of cell attachment, by adding staggered 
posts intended to protect the cells from the shear forces associated with the high 
perfusion rates.  
 An artificial liver sinusoid with a microfluidic endothelial-like barrier has also 
been developed for primary hepatocyte culture to imitate the mass transport 
properties of the hepatic microcirculation.[25]  The unit consisted of a cord of 
hepatocytes fed by diffusion of nutrients across an endothelial-like barrier by a 
convective transport vessel.  Rat and human hepatocytes were sustained for several 
days with this configuration with no extracellular matrix (ECM) coating.  The 
channels were designed to allow for a ratio of convective to diffusive flow in the flow 
channel and a ratio orders of magnitude lower in the cell culture channel, to allow for 
lower shear stresses while still allowing for nutrient exchange through diffusion 
across the endothelial-like barrier.   
 Hepatocyte spheroids have been cultured in wells on a microfabricated chip 
by Fukuda et al.[26]  Another microbioreactor, developed by Kim et al., consists of a 
device in which a biocompatible self-assembling peptide hydrogel, Puramatrix, is 
hydrodynamically focused in the middle of main channel.[27]  Toh et al. have 
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developed a microchannel in which a collagen solution containing hepatocytes is 
immobilized in a microchannel with perfusion.[28]  Hepatocytes have also been 
cultured on a microfabricated poly(ethylene glycol) (PEG) brush surface.[29] 
 
 
2.2 Microfluidics 
2.2.1 Advantages 
  
 Microfluidic cell culture offers a number of advantages over conventional cell 
culture methods.  These include higher throughput, increased surface-area-to-
volume ratios, smaller effective culture volumes, and laminar flow. 
 Microfluidic cell culture allows for higher throughput.  It allows for the use of 
lower cell numbers and lower reagent volumes.  In the case of drug screening, for 
example, microfluidic cell cultures could allow for greater efficacy.   
 Another advantage of microfluidic cell culture is the higher surface area-to-
volume ratios at the microscale.  For example, whereas a 35 mm dish with 1 mL of 
medium in it has a SAV ratio of 11 cm-1, cells cultured in a microchannel of 
dimension 100 µm x 100 µm x 3 cm (H x W x L), a volume of 300 nL, are in an 
environment with a SAV of 400 cm-1.  Larger SAV ratios allow for more efficient 
mass transport of gases by diffusion to and from cells, assuming the microchannel is 
constructed of a gas-permeable polymer.[30]  Figure 1 illustrates qualitatively the 
difference in SAV ratio between a dish and microchannels. 
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Figure 1. Surface area-to-volume ratio difference between a dish and 
microchannels. 
 
 The concept of effective culture volume (ECV), introduced by Walker et al. 
(2004)[31], indicates the ability of the cell to control its microenvironment during 
culture.  Factors affecting the ECV include the magnitude of mass transport along 
each axis and the effects of diffusion and convection.  For a cell in a microchannel, 
mass transport is limited to the x-axis along the length of the microchannel due to 
the short diffusion distances along the y- and z- axes, across the span of and from 
the top to the bottom of the microchannel, respectively.  In contrast, the ECV of a 
cell in a 35 mm dish is less controlled, as mass transport is not limited to one 
dimension.  Convective and diffusive transport may occur equally along all three 
axes as opposed to one axis at the microscale.  Because in vivo environments are 
defined by small ECVs, cell culture in a microfluidic environment may allow for a 
more in vivo-like environment than cell culture at the macroscale.   
  Laminar flow is a condition in which the velocity of a particle in a fluid stream 
is not a random function of time.  The flow regime of a fluid flow, laminar or turbulent, 
is determined by its Reynolds number.  The Reynolds number can be calculated by  
     
       Equation 1  
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where ρ is the fluid density, υ is the characteristic velocity of the fluid, µ is the fluid 
viscosity, and Dh is the hydraulic diameter.  The hydraulic diameter is a computed 
value that depends on the channel’s cross-sectional geometry.  Re < 2300, as 
calculated by the above formula, generally indicates a laminar flow.  Due to the small 
size of microchannels, flow is almost always laminar.  For the purpose of liver cell 
culture, laminar flow may be advantageous as the fluid flow over the cells is more 
steady and predictable and this may be advantageous for autocrine as well as 
paracrine cell signaling.[30] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3 Materials and Methods 
3.1 Microfabrication  
3.1.1 Microfluidic Device Materials 
 
 The methods that exist for fabricating microfluiduic devices include soft 
lithography, micromachining, embossing, in situ construction, injection molding, and 
laser ablation.[30]  We used PDMS devices generated from a soft lithography 
process of molding PDMS from SU-8 photoresist patterns on silicon wafers in our 
experiments.  PDMS molding is faster and less expensive than the other methods 
mentioned, but this method was primarily chosen due to the high gas permeability 
and biocompatibility of PDMS.  The following equations for oxygenation[32], when 
applied to our PDMS devices along with the oxygen consumption and oxygen 
gradient values given with the equations, demonstrate that our devices would be 
adequately oxygenated.    
 
Equation 2 
where oxygen consumption in mols/device/day XO2consumption is calculated from the 
cell density in the microdevice Ncells/cm2, the oxygen consumption of a single 
hepatocyte per second Xonecell=1 x10-16 mols/cell/sec, and the area for the cell culture 
Sdevice. 
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Equation 3 
where Fmax is the amount of oxygen that could be supplied into a device in 
mols/device/day and is estimated from the permeability of oxygen in PDMS DPDMS, 
the thickness of the PDMS wall of the device Δz, and the oxygen concentration 
gradient across the wall of the device ΔC.  
 For a Design 1 (see 3.2.1 4-Channel Design) microchannel (5 mm L x 200 µm 
W x 100 µm H) with a PDMS ceiling 3 mm thick, Sdevice = 5 cm x 0.02 cm = 0.1 cm2 
and if the channel were to contain 500 cells (a number greater than that observed in 
our experiments) and Ncells/cm2= 5,000 cells/cm2, the oxygen consumption of the cells 
in mols/device/day would equal 
X02consumption = 4.32 x 10-9 mols/device/day 
 
where maximum oxygen available would be, assuming an oxygen permeability in 
PDMS of 4.1 x 10-5 cm2/sec, an oxygen concentration gradient of 2 x 10-7 mol 
O2/cm3 [32], and a PDMS ceiling thickness of 3 mm,  
 
Fmax = 2.362 x 10-7 mols/device/day 
for a cell culture area of 0.1 cm2. 
  
Therefore the amount of oxygen available is two orders of magnitude higher than 
that necessary to maintain the cell culture.  The level of oxygen consumption is on 
the same or lower order of magnitude for the other device designs tested, as the 
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surface area Sdevice was the same or greater with a similar or lower cell number for a 
cell density near or less than the value calculated above. 
 
3.1.2 Masters and PDMS 
 
 To generate a PDMS device, a “master” was first fabricated from using 
photolithography.  75-mm diameter silicon wafers were spin-coated with SU-8 
negative photoresist at a spin speed determined by the desired thickness of the 
pattern, i.e. the height of the microchannel or well.  For example, a spin speed of 
1650 rpm would be used to coat silicon wafers with SU-8 at a thickness of 100 µm.  
The coated wafers were then soft-baked on an aluminum hotplate or in an oven at 
95oC after ramping from 65oC, with differing times depending on the thickness of the 
photoresist. 
 To pattern the photoresist, the pattern was first printed on transparencies with 
a resolution of 3556 DPI to create a photolithographic mask.  The coated and soft-
baked wafers, covered with the mask, were then exposed to UV to crosslink the 
areas exposed by the transparency.  After a post-exposure bake at 95oC on an Al 
hotplate or in an oven, ramped from 65oC, for varying times depending on the 
photoresist thickness, the wafers were then developed to remove the unexposed 
photoresist.  Then the patterned wafer was hard-baked on an Al hotplate or in an 
oven at 150oC to anneal the remaining patterned photoresist.   
 To create the final PDMS device, PDMS elastomer and curing agent were 
first combined in a 10:1 ratio, mixed, and desiccated to remove bubbles.  Then after 
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placing the master in a 100 mm polystyrene petri dish, or in later experiments, in an 
aluminum “cup” shaped to hold the master, the PDMS elastomer and curing agent 
mixture was poured over the masters and cured at 80oC, or in later experiments at 
150oC for a shorter period of time.  The patterned PDMS was then peeled off of the 
master and sterilized and placed on a cell culture surface (polystyrene or collagen I) 
or plasma cleaned, bonded to another surface (another PDMS layer, or glass), and 
then sterilized and placed in a petri dish for cell culture.  The process flow for making 
the masters and PDMS devices is shown in Figure 2. 
 
Figure 2. Microfabrication process flow for PDMS devices used in cell cultures. 
 
 
3.2 Device Designs 
 
 The device designs tested differed in the shape of the cell culture area but 
were all fabricated in PDMS.  Initial experiments were done in a device design 
consisting of a microchannel.  The next design consisted of a microchannel in which 
the cells were inserted into a chamber in the center that was encased by posts so 
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that the cells would potentially stay within the chamber.  In the third design, we 
placed wells in a layer below a layer consisting of channels to see whether the cells 
would settle and stay viable and express hepatocellular functions while cultured in 
the wells.  In our fourth design, we tested the cells again in channels with no wells 
but with a collagen I – coated glass surface instead of a collagen I – coated 
polystyrene surface as with the initial microchannel experiments, and with a different 
type of cell.   
 Experiments with Design 1 used murine hepatic progenitor cells (HPCs). 
Experiments with Designs 2, 3, and 4 were done with cells from the human HepG2 
hepatocarcinoma cell line instead of with HPCs.  As shortcomings of each design 
were discovered the design evolved, thus the experiments consisted of testing each 
design in series. 
3.2.1 Design 1 – 4-Channel Design with Varied Channel Width 
 
Design 
 The first microfluidic device consisted of four microchannels with varied width 
and the same length and height.  This variation allowed for the testing of the 
hypothesis that the channel width would affect the viability or the hepatocellular 
function of the cells.  
Channel Dimensions: 50 mm x 100 µm x (100 µm to 400 µm) (L x H x W) 
Port diameter:  4 mm (1.2 mm in design below but cored with larger cork borer) 
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Figure 3. Photolithographic mask  
 
 
 
 
 
Figure 4. Si and SU-8 master for fabrication of the PDMS microchannel device.  The 
substrate is a 75 mm-diameter silicon wafer with the SU-8 photoresist pattern raised 
above the wafer surface.  Shown are the microchannels with numbers and lines 
marking each millimeter along the 50 mm microchannel, with a 1.2 mm diameter port 
at each end of each channel. 
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Figure 5. Side view of a channel in a Design 1 device. 
 
Device Operation 
 To load cells into the PDMS device made from the photolithographic mask 
shown in Figure 3 and the master shown in Figure 4 (device side view shown in 
Figure 5), the device ports first had to be cored with a cork borer to allow access to 
the microchannels.  The devices were then dipped in 70% ethanol (EtOH) for a few 
seconds and dried under UV in a laminar flow hood for a minimum of 30 minutes.  
Then the PDMS molds were placed inside a 35 mm polystyrene petri dish.  The 
bottom surface of the channels was coated with collagen I by flowing the collagen I 
through the channels, allowing it to sit at room temperature under UV for a minimum 
of one hour, rinsing with phosphate buffered saline (PBS) and sterile H20, and then 
rinsing with the medium used to culture the murine HPCs.  The collagen solution 
used in all experiments was rat tail collagen type I at a concentration of 50 µg/mL of 
collagen in 0.02 N acetic acid.  Control 35 mm dishes were coated with collagen I 
with the same set of steps as described for the devices.  
 Cell loading was done using various methods.  Prior to seeding, the channel 
was already wetted with medium.  The first method was to simply pipet the cells into 
one port and allow the fluid flow to drive cells into the channel. As this failed to drive 
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enough cells into the channel, another method that was tested was tilting the 
devices at an approximately 15o to 30o tilt immediately after loading a port with cells 
and allowing the cells to enter the channel for a couple of minutes with intermittent 
observation under a microscope.  This method had better results than the first 
method.  In later experiments with this device, the port size was increased to 4 mm 
by coring larger ports.  This increased the ease of cell loading by allowing for larger 
volumes of the cell mixture to be added and facilitating medium changes and sample 
collection by increasing ease of access with the pipette. 
 In all experiments, devices were placed in Falcon™ (Becton Dickinson, 
Franklin Lakes, NJ) petri dishes for the cell culture.  A couple of milliliters (0.5 mL to 
5 mL depending on the dish volume) of the cell culture medium used for the culture 
were then pipetted into the area outside the device, to keep the area around the 
device humidified once the devices were incubated (at 5% CO2 and 37oC in all 
experiments).  A lid was placed on the petri dish during the cell culture.   
 
3.2.2 Design 2 – Spheroid Chamber Design 
Design 
 The purpose of the second design was to attempt to create and maintain 
three-dimensional hepatocellular aggregates, or spheroids, within a microscale 
culture chamber. Spheroids are advantageous for mimicking hepatocellular functions 
because hepatocytes cultured to self-assemble into multicellular spheroids possess 
tight junctions and microvilli-lined channels that contain bile[33] and maintain liver-
specific functions, such as high albumin secretion, urea excretion, and cytochrome 
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p450 activity over a period of several weeks, whereas non-aggregated hepatocytes 
do not.[34] By allowing for liver tissue to be cultured in three dimensions in a 
potentially more in vivo-like environment at the microscale, the design would allow 
for greater accuracy and relevance of studies on the cultured tissue.  
 The second design (Figures 6-7) consisted of a rectangular cell culture 
chamber with a linear array of posts on two sides to prevent cell clusters from 
flowing out of the chamber and inlet and outlet microchannels to allow for fluid flow.  
This design allowed for direct access with a pipette to the rectangular chamber.  By 
coring a cylindrical hole in the PDMS directly above the rectangular chamber the 
cells could be directly added with a pipette.  The length and width dimensions of the 
rectangular area were large enough to allow for the formation of large clusters of 
hepatocytes. 
Dimensions 
Rectangular Cell Culture Chamber:  
1.8 mm x 1.2 mm x 100 µm (L x W x H) (layer above is cored with a 1.2 mm cork 
borer) 
Posts: 200 µm x 50 µm x 100 µm (L x W x H) 
Gaps between Posts around Cell Culture Chamber: 100 µm wide 
Inlet and outlet microchannels: 6 mm x 400 µm x 100 µm (L x W x H) 
Port diameter: 4 mm (1.2 mm in design below but cored with larger cork borer) 
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Figure 6.  Top view of the spheroid chamber design.  Cells were added with a 
pipette to a port cored above the central rectangular cell culture chamber.  The linear 
arrays of posts on each side of the rectangular area were added to prevent cell 
clusters from flowing out of the central area. 
 
 
Figure 7. Side view of the spheroid chamber design. 
 
Device Operation 
 The PDMS above the cell culture chamber in each device was first cored with 
a 1.2 mm cork borer.  The ports were cored with a 4 mm cork borer.  The devices 
were then sterilized by soaking in 70% ethanol for 30 minutes and drying under UV 
overnight.  Each device was then placed in a separate uncoated tissue-culture-
treated 35 mm polystyrene dish.  In experiments with Design 2, the HepG2 cells 
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were cultured on uncoated tissue-culture-treated polystyrene as this was the 
standard method of culturing HepG2 cells in the lab. 
 Cells were seeded into the device using different methods.  In all experiments 
the devices were wetted with medium prior to adding cells.  The first method was to 
inject cells into the cored hole above the cell culture chamber of the device with a 
pipette.  This was done by suctioning a few µL of the cell mixture into a pipet tip with 
a pipette, placing the pipet tip in the hole cored above the culture chamber, and 
pipetting the cells into the culture chamber.  The pipette and pipet tip were then 
removed from the cored hole.  The second method of adding cells was to, having 
suctioned cells into the pipet tip with a pipette, place and then remove the pipette 
from the hole cored above the cell culture chamber while keeping the pipet tip in 
place in the cored hole, thus allowing the cells in the cell mixture in the pipet tip to 
settle into the cell culture chamber via gravity.  The first method of injecting the cells 
proved to be a more effective method as more cells were seeded using this method. 
 
3.2.3 Design 3 – Connected 4-Channel and Well Design 
Design 
 To see how the cells would react to being cultured in a layer separate from 
the perfusion channel, Design 3 incorporated a separate well layer for the cell 
culture.  This method also allowed for the investigation of how cells react to being 
placed in a  cylindrical structure; this method was tested as a potential method of 
inducing aggregation into a spheroidal aggregate. 
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 In this design, a series of connected channels was placed over a linear array 
of wells so that each channel was placed over one well (see Figures 8-9).   
 Devices made from Design 3 were two layers whereas all other devices were 
comprised of one layer.  The device fabrication required two masters; one consisting 
of a series of wells and one consisting of the pattern of channels placed above the 
wells.  Separate molds were made from each master and these were then bonded 
after plasma cleaning. 
Dimensions 
Port diameter: 4 mm (1.2 mm in design below but cored with larger cork borer) 
Channels: 500 µm x 100 µm (W x H)   Wells: 300 µm diameter x 100 µm H 
 
 
 
 
 
Figure 8. Top view of both layers (channels and wells) of Design 3.  The pattern 
above is an overlay of the masks used to generate both layers of the PDMS devices. 
 
 
 
Figure 9. Side view of Design 3. 
 
 26 
Device Operation 
 First the ports in the top layer were cored with a 4 mm cork borer.  Then after 
cleaning the surfaces of the devices with Scotch tape, the devices were placed in a 
plasma cleaner and plasma cleaned for 30 seconds.  After plasma cleaning, the 
devices were bonded while alignment was done using a stereoscope.  After plasma 
cleaning and bonding, the devices were placed in a sterile 100 mm polystyrene petri 
dish and placed under UV in a laminar flow hood overnight.  In the initial 
experiments with this device, channels were not wetted prior to sterilization, and the 
channels had to be debubbled.  This was done by placing tubing connected to a 
syringe in one port, closing off the other port, and adding fluid with the syringe and 
pressurizing the device.  However, in later stages of experiments with this device, 
sterile water was added to the bonded channels immediately after bonding, to allow 
for continuity and eliminate bubble formation once medium was later added to the 
channels for cell culture. 
 Various methods were attempted for loading cells into this device, other than 
adding the cell mixture to the inlet port while leaving the device on a flat surface.  
One was to tilt the dish containing the device.  Another method was to insert a 
cylindrical piece of PDMS with a diameter similar to the diameter of the inlet port (as 
the PDMS piece was made by removal of cored PDMS from the inside of a 4 mm 
cork borer) into the inlet port, after adding cells to the inlet port, to drive the cell 
mixture into the device, and then remove the PDMS piece from the port after the 
devices had been incubated for approximately an hour.  Neither method was 
consistently more successful at increasing the cell number in the devices. 
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3.2.4 Design 4 – Connected 4-Channel Design 
Design 
  For a more basic study of cell viability and hepatocellular function in 
microfluidic channels, the wells in the third design were eliminated in the fourth 
microfluidic device design (Figure 10).  This would allow the cells to be cultured in a 
channel instead of a cylindrical area.  In addition, the cells were cultured on collagen 
I – coated glass instead of tissue-culture-treated polystyrene.  This method was 
used because the collagen I coating on glass is another standard method of 
culturing HepG2 cells.  
Dimensions 
Port diameter: 4 mm (1.2 mm in design below but cored with larger cork borer) 
Channels: 500 µm W x 100 µm H 
 
Figure 10. Top view of Design 4. 
 
Device Operation 
 To prepare this device for use it was first cored with a 4 mm cork borer, 
plasma cleaned for 30 seconds, bonded to glass, and then immediately wetted with 
sterile deionized water.  Then collagen I was run through the channels by placing a 
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drop of collagen over one port and using suction from a 1 cc syringe without a 
needle to pull the collagen through the channels.  The devices were then placed with 
the collagen in the channels under UV in a laminar flow hood for one hour, after 
which the channels were rinsed with PBS and sterile H20 and then HepG2 medium.  
Wells of a 48-well plate were coated alongside the devices with the same set of 
steps.   
 Cells were loaded by reducing the fluid volume to a minimum in both ports 
and adding cells to one port, allowing fluid flow to drive the cells from the port into 
the channels.  This was done by first removing fluid from both ports with a pipette.  
Then the cell mixture was suctioned into the pipette and pipetted out into the inlet 
port.  The difference in fluid height drove the flow of the cells from the inlet port into 
the channel and the outlet port. 
3.3 Cell Culture 
3.3.1 Hepatic Progenitor Cells 
 C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, 
ME). All animals were maintained on a rodent chow under a constant day/night 
cycle. Six to eight week old mice were used in all experiments. All care and use of 
animals was approved by the Institutional Animal Care and Use Committee at the 
University of North Carolina at Chapel Hill in accordance with the principles and 
procedures outlined in the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals. 
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3.3.1.1 Isolation 
 A modification of the two-step collagenase perfusion technique described by 
Seglen et al.[35], slightly modified from a protocol for isolation of HPCs described by 
Wang et al.,[36] was used to isolate the liver  cells from adult C57/BL6 mice.  All 
initial isolation steps were conducted on ice to keep cells metabolically dormant.  
The cells were stored in HPC isolation medium (described below) prior to seeding 
and cultured in routine HPC growth medium (described below). 
 The isolated HPCs were initially stored on ice prior to seeding, in medium 
consisting of L-15 (Leibovitz) medium plus 0.20% bovine serum albumin (BSA), 20 
mM Hepes, 2 µm dexamethasone, 1X antimycotic-antifungal (AA), 0.5 mg/L insulin-
transferrin-selenium (ITS), and 0.3 g/L L-glutamine.  Cells were then cultured in 
medium consisting of low glucose Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Invitrogen Corp., Carlsbad, CA) plus 10% fetal bovine serum (FBS), 20 mM Hepes, 
10 mM nicotinamide (niacinamide), 30 mg/L L-proline, 1 mM L-ascorbic acid 2-
phosphate (Asc2P), 2 µm dexamethasone, 1X AA, 0.5 mg/L ITS, 10 ng/mL 
epidermal growth factor (EGF), 1% dimethyl sulfoxide (DMSO), and Gentamicin in a 
ratio of 1:1000 by volume.  In all experiments, the cells were cultured in an incubator 
at 5% CO2 and 37oC.   
3.3.2 HepG2 Cells 
 HepG2 cells were obtained from stocks from various passages that were 
stored in liquid nitrogen.  The cells were first cultured in a flask and then trypsinized 
to detach the cells from the flask surface.  In some experiments the cells that were 
seeded in devices were ones that were then divided from this stock into separate 
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vials that were then stored at -80oC.  In other experiments cells were seeded directly 
after this first round of plating of the liquid-nitrogen-frozen stock and trypsinization. 
The cells were trypsinized and reseeded as described below.  
3.3.2.1 Cell Preparation 
 The HepG2 cells plated in the flask were first rinsed with 1X phosphate 
buffered saline (PBS).  The PBS was removed and trypLE, or trypsin in initial 
experiments, was then added and the cells were incubated until detachment of most 
of the cells from the surface was observed under the microscope.  PBS was then 
added and the entire cell mixture was transferred to a centrifuge tube and 
centrifuged at 1100 rpm for 5 minutes.  The supernatant was then removed and 
medium was added and the mixture was agitated with pipetting to break up the cell 
pellet.  A sample of the cell mixture was then combined in a 1:4 ratio with trypan blue 
and the cells were counted using a hemacytometer to obtain the cell concentration.  
The cells were recentrifuged and resuspended for the desired cell concentration for 
cell seeding.  The medium used with HepG2 cells was HepG2 medium containing 
10% FBS.  The HepG2 medium consisted of Eagle’s Minimum Essential Medium 
(EMEM) (Invitrogen Corp., Carlsbad, CA) plus 0.1 mM non-essential amino acids, 
1.0 mM sodium pyruvate, and 5 mL antimycotic-antifungal (AA) solution (Sigma Cat. 
# 5955) per 500 mL medium.   
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3.4 Assays 
3.4.1 Cellular Viability 
Three assays were used: MitoTracker, Trypan Blue, and Live/Dead. 
MitoTracker™ probes (Molecular Probes, Eugene, OR) are a series of 
mitochondrion-selective dyes.  The MitoTracker Red™ dye, once it enters an 
actively respiring cell, is oxidized to the MitoTracker Red™ fluorescent probe once it 
is sequestered in the mitochondria.  The dye used was 90 nM MitoTracker Red™.  
 Trypan blue is used to selectively color dead cells blue.  In a viable cell trypan 
blue is not absorbed; however, it traverses the membrane in a dead cell. 
 The calcein AM stain is based on the conversion of the virtually 
nonfluorescent cell-permeant calcein AM to fluorescent calcein.  The dye is well 
retained within live cells, producing a green fluorescence (excitation/emission ~495 
nm/~515nm).  In contrast Ethidium homodimer-1 (EthD-1) enters cells with damaged 
membranes and undergoes an enhancement of fluorescence upon binding to 
nucleic acids, thereby producing a red fluorescence in dead cells (ex/em ~495 
nm/~635 nm).  EthD-1 is excluded by the intact plasma membrane of live cells. 
 
3.4.2 Cell Number 
 The MTT assay is a colorimetric assay used to measure cellular proliferation.  
The assay measures absorbance from formazan, based on the reduction of yellow 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) to 
purple formazan in the mitochondria of living cells.   
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3.4.3 Albumin Secretion Assay 
 Albumin secretion was measured using an ELISA (enzyme linked 
immunosorbent assay).  The ELISA is a biochemical technique for measuring the 
presence of a certain antigen, e.g. albumin, in a given sample.  The antigen is 
immobilized on a surface, e.g. a 96-well plate, and one then washes a particular 
antibody over the surface.  The antibody is linked to an enzyme that reacts when 
activated, e.g. by light, as with a fluorescent enzyme.  The brightness of the 
fluorescence then indicates the amount of antigen in the sample.   
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3.5 Experiments Conducted 
3.5.1 Design 1 
 Three experiments were performed with this design, each with HPCs isolated 
from C57BL/6 mice.  
3.5.1.1 Experiment 1 
 Cells were seeded in four devices.  Cells were observed for five days and the 
medium was changed at one hour and one day post-cell seeding.   
Assay - Viability 
 At Day 4 post-cell seeding, the cells were assayed for viability with the 
MitoTracker Red™ stain. After dye addition to four devices and control dishes and a 
wait period of a minimum of 5 minutes, the results were analyzed using a Zeiss LSM 
410 inverted microscope.  The same microscope was used in all microscopic 
analyses discussed. 
3.5.1.2 Experiment 2 
Cells were seeded in one device at 2000 cells/µL. 
Assay – Cell Number 
 An MTT assay was conducted on Day 0 to measure the cell number in each 
channel.  A standard curve was generated by seeding approximately 100 to 20,000 
cells per well in a 96-well plate.  MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) solution was added to the channels and the cells were 
incubated for 3 hours in an incubator at 5% CO2 and 37°C.  The cells were then 
incubated with MTT solvent (0.1 N HCl in anhydrous isopropanol) until the purple 
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formazan crystals were dissolved.  The absorbance was read at 570 nm using an 
ELISA plate reader.  The cell number was calculated from the standard curve. 
 
3.5.1.3 Experiment 3 
 Cells were maintained in culture in four devices for five days total with 
medium changes at one hour and one day post-cell seeding and at Day 4 post-cell 
seeding the spent medium was collected for an albumin ELISA.  An error to be noted 
for this experiment is that the cell culture medium contained double of each of the 
components, i.e. the components were added twice to the same bottle of medium.  
The only other cell culture to which this error applies is the cell culture used in 
Experiment 4 with Design 1 (Section 3.5.1.4 below). 
Assay – Albumin Secretion 
Medium was collected from both ports of the devices on Day 4 and assayed for 
albumin with an ELISA. 
3.5.1.4 Experiment 4 
 Four cells were seeded and of these three devices were maintained in cell 
culture for eight days total. 
 In the three devices maintained in culture, medium was changed at one hour, 
Day 1, Day 2, Day 3, Day 4, and Day 7 post cell-seeding.  Samples were taken from 
the spent medium from the Day 4 and Day 7 medium changes for two albumin 
ELISA assays. 
Assay – Albumin Secretion 
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 Medium was collected from both ports of the devices on Day 4 and assayed 
for albumin with an ELISA.   The medium collected was from a 24 hour sample as 
medium was changed on Day 3.  The medium was replaced and the devices were 
returned to the incubator. 
 Medium was then collected on Day 7 and assayed for albumin with an ELISA.  
The medium collected was from a 72 hour sample as medium was previously 
changed on Day 4. 
Assay – Cell Number 
 The fourth device was seeded as were the other three and was used for an 
MTT assay.  A standard curve was done concurrently with the fourth device.  The 
protocol followed for the MTT assay was the same as that used for the MTT assay 
described in Section 3.5.1.2. 
 
3.5.2 Design 2 
 Two experiments were conducted with this design, both with HepG2 cells 
thawed from storage in liquid nitrogen. 
3.5.2.1 Experiment 1 
 Cells were thawed and plated in a T25 flask in HepG2 medium, cultured for 
11 days, and then seeded in devices on Day 11 post-cell seeding.  Medium was 
changed in the flask on Days 4, 7, and 10.  Devices were seeded at 5000 cells/µL.  
Controls were seeded with 125,000 cells/500 µL HepG2 medium in a 48-well plate.  
This seeding concentration was higher than that specified by the standard protocol 
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for the lab which is 19,000 cells/500 µL in a well of a 48-well plate for a 25,000 
cells/cm2 cell seeding density.  This seeding density used was based on a protocol 
specifying 250 cells/µL.  Seeding of the first of three devices was semi-static; i.e., 
the cells were allowed to settle in a pipet tip while observing the uncapped dish 
under a microscope.  Cells were injected into the other two devices and the cell 
seeding was conducted under sterile conditions in a laminar flow hood.  The volume 
of the cell mixture injected based on observation of the device under the 
microscope; cells were added until the cell culture chamber was observed to have 
been moderately seeded.  The volume of the medium used to humidify the dishes 
(pipetted on the dish area surrounding the device) was 0.5 mL.  The cells were 
imaged and the medium around the devices, used for humidification, was emptied 
and refreshed with a pipette on Days 1, 3, 4, and 5 of the cell culture.       
Assay - Viability 
 To characterize how the cells would respond to static culture over an 
extended period, HepG2 cells were assayed for viability on Day 6 with a trypan blue 
stain. 
 A solution of 10% trypan blue in 1X PBS was used for the stain.  To stain the 
cells the medium in the channels was replaced with the stain by emptying the device 
ports with a pipette and filling one of the two ports of each device with the stain and 
allowing it to flow into the cell culture area.  To stain cells in the control wells, the cell 
culture medium was removed and replaced with the stain.  After a minimum of 10 
minutes, the trypan blue was replaced with PBS and the cells were imaged.   
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3.5.2.2 Experiment 2 
 Cells were added to six devices at 1000 cells/µL.  The controls were three 
wells of a 48-well tissue-culture-treated polystyrene plate, seeded with 19,000 cells 
(in 19 µL medium) added to 481 µL medium for a surface cell density of 25,000 
cells/cm2 per the lab protocol.  The volume of the medium used to humidify the dish 
area was 1 mL, as opposed to 0.5 mL in the previous experiment, to ensure 
adequate humidification.  The cells were imaged on Days 1, 2, and 5.  The medium 
around the device was refreshed on Day 2 of the cell culture.  Also, whereas 35 mm 
dishes were used to contain the devices in Experiment 1 with Design 2, 60 mm 
devices were used in Experiment 2 with Design 2 (due to unavailability of the 
dishes). 
Assay - Viability 
 As viability was difficult to determine with the trypan blue stain, the cells were 
assayed for viability on Day 6 with the Calcein AM/Ethidium homodimer-1 (EthD-1) 
Live/Dead cell stain (Invitrogen Corp., Carlsbad, CA). 
 The cells were rinsed with 1X PBS prior to addition of the stain.  A solution of 
5 µL of 4 mM Calcein AM and 20 µL of 2 mM EthD-1 in 10 mL of 1X PBS was then 
added to the devices and control wells.  The cells were incubated with the stain for 
30 minutes prior to imaging. 
 
3.5.3 Design 3 
 Four experiments were performed with Design 3, each with HepG2 cells 
thawed from storage in liquid nitrogen. 
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3.5.3.1 Experiment 1 
 Cells were seeded in three devices at 5000 cells/µL.  Approximately 19,000 
cells were seeded in three control wells of a 48-well tissue-culture-treated 
polystyrene plate; 485 µL HepG2 medium were added for a total volume of 500 µL.  
The cells were kept in static culture for four days after cell seeding.   
Assay – Viability 
 A Calcein AM/Ethidium homodimer-1 live/Dead cell stain was done on Day 4 
post-cell seeding to test viability.  A solution of 2 µL (instead of 5 µL per protocol, 
due to unavailability of solution) of 4 mM Calcein AM and 5 µL of 2 mM EthD-1 in 10 
mL 1X PBS was used for this experiment.  The cells were rinsed with 1X PBS prior 
to addition of the stain and incubated for a minimum of 30 minutes after addition of 
the stain prior to imaging.  
3.5.3.2 Experiment 2 
 Cells were seeded in four devices at 1,375 cells/µL.  Three control wells of a 
48-well plate were seeded with 19,000 cells in HepG2 medium for a total medium 
volume of 500 µL.  One deviation from the protocol is that a temperature of 4oC was 
used during centrifugation during the protocol for cell trypsinization from the T25 
flask in which the cells had been cultured prior to device seeding.  
 In this experiment the cells were kept in static culture for four days.  The cells 
were kept in static culture to minimize the alterations between this experiment and 
the previous one, while increasing the concentration of the live/dead cell stain used 
to assess viability.   
Assay - Viability 
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 A solution of 60 µL of 1 mM Calcein AM and 60 µL of 2 mM EthD-1 in 3 mL 
1X PBS was used.  Cells were incubated for 45 minutes prior to imaging.  The cells 
were also re-imaged, although these images are not shown, prior to which they were 
flushed with medium instead of PBS.   
3.5.3.3 Experiment 3 
 Cells were seeded in 5 devices at 10,000 cells/µL.  Three wells of a 48-well 
plate were seeded with 19,500 cells per well with 500 total µL of culture medium.  
Note that this is a deviation from the standard protocol, which specifies a seeding 
concentration of 19,000 cells in 500 µL of medium per well of a 48-well plate.  
Devices 1, 3, and 4 were seeded by inserting a PDMS piece in the inlet port (see 
Materials and Methods Section 3.2.3) after the cell mixture had been added to the 
inlet and removing the PDMS piece only after incubating the devices for 64 minutes.  
This  method was not used for Devices 2 and 5 as a large number of cells was 
observed to have entered the channels on their own. 
Assay - Viability 
 In this experiment as with the previous two described with Design 3, the cells 
were kept in static culture.  However in this experiment, the cells were assessed for 
viability earlier to see how viability would differ earlier in the cell culture.   
 A stain solution of 40 µL of 1 mM Calcein AM and 40 µL 2 mM EthD-1 in 2 mL 
HepG2 medium was used.  Cells were incubated 45 minutes prior to imaging. 
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3.5.3.4 Experiment 4 
 In this experiment, two different sets of devices were used: one set which 
consisted of the Design 3 channel-and-well devices, and one set which consisted of 
the Design 4 (see Section 3.2.3) devices.  
 The cells used were from Passage 109 and were initially plated in a T25 flask 
prior to seeding in devices and controls.  A note regarding the cells used in this 
experiment is that they had initially looked non-viable when, based on qualitative 
observation under a microscope, but after incubation for six days with no medium 
change, the cells looked viable based on observation under a microscope.  At this 
point the medium used for the cells was changed.  The cells were then seeded the 
next day in devices and controls. 
 Two Design 3 devices and three Design 4 devices were seeded at 2000 
cells/µL.  Four control wells of a 48-well plate were seeded with 19,000 cells in 500 
µL HepG2 medium.   
 In this experiment a medium change was done on Day 1 in addition to the 
medium change at one hour post-cell seeding.  The medium change for the devices 
was done by nearly emptying the ports with a pipette, adding warmed medium to 
one port and re-incubating the devices, allowing the fluid to flow from one port to the 
other.  Medium was also changed in the controls  
Assay - Viability 
 The stain solution used for the Day 2 stain consisted of 2.5 mL HepG2 
medium containing 50 µL of 2 mM EthD-1 and 12.5 µL of 4 mM Calcein AM. 
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3.5.4 Design 4 
 Four experiments were conducted with Design 4 (including the experiment 
discussed in section 3.5.3.4).  Each was conducted with HepG2 cells thawed from 
storage in liquid nitrogen. 
3.5.4.1 Experiment 1 
 HepG2 cells were seeded in three Design 4 devices and 2 control wells.  The 
devices were seeded at 5000 cells/µL and the controls were seeded at 19,000 cells 
were well in 500 µL HepG2 medium.  A medium change was conducted at one hour 
post-cell seeding. 
Assay - Viability 
 The stain solution used for the Day 2 EthD-1 stain consisted of 1.5 mL HepG2 
medium with 30 µL of 2 mM EthD-1. 
 A live/dead cell ratio was obtained using bright-field phase contrast images 
and dead cell stain fluorescent images taken of each of four channels of each of the 
devices.  The number of dead cells in a given image was subtracted from the total 
number of cells in that area, counted from the bright-field image.  Assuming the 
number of live cells in that area was the difference between these numbers, the live 
to dead cell ratio was calculated.  
Assay – Albumin Stain 
 The albumin stain was done as follows.  The devices and control were first 
rinsed with 1X PBS.  Then a solution of 4% paraformaldehyde was run through the 
devices and control for fixation.  After a 20 minute wait, a solution of PBS containing 
0.1% Triton was run through the devices and control as a rinse.  After the rinse, a 
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solution of PBS containing 0.1% Triton and 10% horse serum was run through the 
devices and control as a blocker.  After this step, the devices and control were again 
rinsed with a solution containing 0.1% Triton.  After the rinse, the primary antibody 
was added, in a 1:500 dilution in PBS (Sigma Inc., Catalog # A6684, Lot 03K348).  
After a 2 hour wait at room temperature, a PBS rinse, and addition of the secondary 
antibody in a 1:750 dilution, the devices and control were left at room temperature 
for an hour.  The devices and control were then rinsed with PBS and imaged.  
Imaging was done in the following order: red fluorescence, green fluorescence for 
the albumin stain, and bright-field phase contrast. 
3.5.4.2 Experiment 2 
 Cells were seeded in four devices at a concentration of 2000 cells/µL and in 
two control wells at 19,000 cells/well in 500 µL HepG2 medium.   Cells were cultured 
for a total of four days.   
Assay – Albumin Stain 
 An albumin stain was conducted on Day 3 post-cell seeding.  The albumin 
stain was done as described above, with a change to the dilutions of the primary and 
secondary antibodies.  Instead of 1:500 and 1:750 dilution of the primary and 
secondary antibodies, respectively, the dilutions used were 1:250 and 1:200 of 
primary and secondary antibody, respectively, in PBS.    
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3.5.4.3 Experiment 3 
 In this experiment, only viability was assayed, using an EthD-1 dead cell 
stain.  Cells were seeded in four devices at 1000 cells/µL and two control wells at 
19,000 cells/well in 500 µL HepG2 medium.  Medium was changed on Day 1 and the 
cells were then imaged.   
Assay - Viability 
 The stain solution used for the Day 2 Ethidium homodimer-1 stain consisted 
of 30 µL of 2 mM Ethidium homodimer-1 in 1.5 mL HepG2 medium.  A live to dead 
cell ratio was calculated using the same method discussed in section 3.5.4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4 Results 
4.1 Design 1 – 4-Channel Design with Varied Channel Width 
4.1.1 Experiment 1 
Viability Stain 
 Below are representative images (Figures 11-15) from the cells in Design 1 
devices with the MitoTracker Red™ dye on Day 4 post-cell seeding.  As viable cells 
fluoresce when stained with MitoTracker Red™, this assay demonstrated the 
viability of cells in the microchannels.  Based on a qualitative assessment of the 
images, a difference in viability was not observed within the range of channel widths 
(100 µm to 400 µm) tested. 
 The cells were also assessed for aggregation or lack thereof.  Cells were 
observed to aggregate in all the channel widths.  Cells were also observed to form 
clusters that spanned the width of the channel and had collected during cell seeding.  
Aggregation was not observed in control dishes.  Cell debris was also observed in 
both the channels and control dishes.  Also bubbles had entered some of the 
channels during cell seeding.  However these channels would not have been able to 
be stained with MitoTracker Red™ and were not included in the representative 
images below. 
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100 µm Channels 
         
Figure 11a                                                       Figure 11b 
Figures 11 a-b. (a) Bright-field and (b) fluorescent images of MitoTracker-stained 
cells on Day 4 post-cell seeding in a 100 µm wide microchannel. 
 
200 µm Channels 
         
Figure 12a                                                     Figure 12b 
Figures 12 a-b. (a) Bright-field and (b) fluorescent images of MitoTracker-stained 
cells on Day 4 post-cell seeding in a 200 µm wide microchannel. 
 
300 µm Channels 
         
Figure 13a                                                        Figure 13b 
Figures 13 a-b. (a) Bright-field and (b) fluorescent images of MitoTracker-stained 
cells on Day 4 post-cell seeding in a 300 µm wide microchannel. 
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400 µm Channels 
         
Figure 14a                                                     Figure 14b 
Figures 14 a-b. (a) Bright-field and (b)fluorescent images of MitoTracker-stained 
cells on Day 4 post-cell seeding in a 400 µm wide microchannel. 
 
Control 
 
Figure 15. Bright-field image of cells on Day 4 post-cell seeding in a collagen I-
coated 35 mm polystyrene dish control. 
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4.1.2 Experiment 2 
Cell Number Assay 
 The MTT assay for cell number, conducted in a Design 1 device on Day 0, 
generated non-linear results (Figure 16) in the assessment of cell number vs. 
microchannel width after cell seeding.  It is to be noted that a qualitative observation 
was recorded that the cell density was similar between channels.  Data are also 
shown after removal of the outlier (Figure 17).  The experiment was not done in 
multiples.  A possible explanation for the outlier is that cells were washed out of the 
200 µm wide channel when MTT solution was added to the channel.   
 The purpose of this assay was to assess the number of cells seeded in each 
of the channel widths, immediately after cell seeding.  However, as cell number in 
the channels was a function of the volume of the cell seeding mixture and other 
factors affecting the cell number, conclusions regarding the effect of channel width 
on cell number seeded cannot be made from the MTT assay alone.  No control dish 
was tested in the MTT assay. 
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Figure 16. Microchannel results of MTT assay for cell number, conducted on Day 0. 
Cell number as calculated from standard curve vs. range of widths of microchannels 
in each device.   
 
  
Figure 17. Results of MTT assay without the outlier.   
4.1.3 Experiment 3 
Albumin Secretion Assay 
 The albumin ELISA conducted on three Design 1 devices from a Day 1-4 
sample (the sample was taken on Day 4 after static culture on Days 1, 2, and 3) 
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indicated an increase in albumin secretion by the HPCs with microchannel width.  
Figure 18 shows albumin concentration versus microchannel width for the devices 
tested.  The cell number was not counted in each channel however, so it is unknown 
whether the increase was due to an increase in cell number or increased 
hepatocellular function. 
 
Figure 18. Mean albumin concentration (N=3) for four microchannel widths (100 µm 
to 400 µm) as determined by the albumin ELISA conducted with samples taken on 
Day 4 after 3 days of static culture. 
 
4.1.4 Experiment 4 
Albumin Secretion Assays 
 The first albumin ELISA from this cell culture, conducted on three Design 1 
devices from a Day 4 24 h sample (the sample was taken on Day 4 after a medium 
change on Day 3), indicated an increase in albumin secretion by the HPCs with 
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microchannel width.  Figure 19 shows albumin concentration versus microchannel 
width for the devices tested.  The results show an increase in albumin secretion with 
microchannel width although the standard deviations vary and do not correlate with 
this increase in albumin secretion.   
 
 
Figure 19. Mean albumin concentration (N=3) for four microchannel widths (100 µm 
to 400 µm) as determined by the albumin ELISA conducted with samples taken on 
Day 4 after conducting medium changes every day of the cell culture. 
 
 The second albumin ELISA from this cell culture, conducted on three Design 
1 devices from a Day 7 72 h sample (the sample was taken on Day 7 after static 
culture from Days 4 to 7), did not indicate an increase in albumin secretion by the 
HPCs with microchannel width.  Figure 20 shows albumin concentration versus 
microchannel width for the devices tested.  
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Figure 20. Mean albumin concentration (N=3) for four microchannel widths (100 µm 
to 400 µm) as determined by the albumin ELISA conducted with samples taken on 
Day 7 after static culture from days 4 to 7. 
 
Cell Number Assay 
 
 The assay failed, based on a standard curve done concurrently with the 
assay as well as the previously done standard curve (Section 3.5.1.2).  The results 
showed negative values for the cell numbers for all channel widths.  Due to the need 
for greater sensitivity with the MTT assay to low cell numbers, it was not possible in 
this assay to correlate the standard curve with positive cell numbers in the device.  
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4.2 Design 2 – Spheroid “Chamber” Design 
4.2.1 Experiment 1 
Viability Stain 
 This exclusion stain conducted on the Design 2 devices showed a 
predominantly non-viable cell population after six days in static culture.  Figures 21 – 
22 show images (10X magnification) from all the devices as well as the control 48-
well plate.  Note that Device 1 was seeded under non-sterile conditions while testing 
seeding methods under the microscope (see Materials and Methods Section 
3.5.2.1).  A mixture of cells and debris is seen in the device wells.  Cells in the 
controls were observed to have seemingly greater viability.  This could be attributed 
to the unknown difference in cell seeding densities; whereas the controls were 
seeded with 125,000 cells in wells of a 48-well plate with a total of 500 µL of culture 
medium (Section 3.5.2.1), an unknown number of cells settled in the wells of the 
devices after an unknown volume (enough to moderately seed the cell culture 
chamber) of cell mixture at 5,000 cells/µL was seeded into the devices.    
Device 1                                                        Device 2 
 
         
Figure 21a                                                       Figure 21b 
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Device 3 
 
Figure 21c 
Figures 21 a-c. Representative images from a trypan blue stain conducted on cells 
in each of three Spheroid Chamber devices on Day 6 post-cell seeding in a static 
culture. 
 
Control Well 1                                           Control Well 2 
         
Figure 22a                                                Figure 22b  
Figures 22 a-b. Images from a trypan blue stain conducted on each of two 48-well 
plate controls on Day 6 post-cell seeding in a static culture. 
4.2.2 Experiment 2 
Viability Stain 
 In another experiment, overlap in the green (live) and red (dead) fluorescence 
seem to indicate autofluorescence in images (Figures 23 a-l) of the Calcein 
AM/Ethidium homodimer-1 live/dead stain conducted on Spheroid Chamber devices 
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on Day 6 post-cell seeding.  However cells lying in different planes may express one 
or the other fluorescence depending on their viability, so autofluorescence is not a 
direct conclusion. 
 The following modifications were made to the protocol between this and the 
previous experiment.  The cell concentration used in this experiment was 1000 
cells/µL as opposed to 5000 cells/µL in the previous experiment, so that a potentially 
larger volume of 1 µL could be pipetted for a desired cell number of 1000 cells/well.  
In addition, the cell seeding density for the control was reduced to 25,000 cells/cm2, 
the value specified by the standard protocol for the lab. 
 Controls also show overlap in green and red fluorescent areas (Figures 24 a-
f).  Again, however, this does not indicate total viability or non-viability of the cell 
culture due to the potential difference in staining of cells in different planes.  
 
Device 1 
         
  Figure 23a                                                           Figure 23b 
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Device 2 
         
Figure 23c                                                             Figure 23d 
Device 3 
         
Figure 23e                                                           Figure 23f 
Device 4 
         
Figure 23g                                                         Figure 23h 
 
 56 
Device 5 
         
Figure 23i                                                       Figure 23j 
Device 6 
         
Figure 23k                                                        Figure 23l 
 
Figures 23 a-l. Calcein AM (green) (live) and ethidium homodimer-1 (red) (dead) cell 
stain conducted in spheroid chamber devices on Day 6 post-cell seeding. 
 
Control 1 
         
Figure 24a                                                     Figure 24b 
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Control 2 
         
Figure 24c                                                  Figure 24d 
Control 3 
         
Figure 24e                                                     Figure 24f 
Figures 24 a-f. Calcein AM (green) (live) and ethidium homodimer-1 (red) (dead) cell 
stain conducted in control wells on Day 6 post-cell seeding. 
 
 
4.3 Design 3 – Connected 4-Channel and Well Design 
4.3.1 Experiment 1 
Viability Stain 
 Low expression of calcein AM fluorescence was observed in the devices and 
the controls on Day 4 post-cell seeding after four days in static culture (Figures 25 
a–l).  A lower calcein concentration than specified by the protocol (due to lack of 
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availability) was used in this assay so this may have resulted in less expression of 
the live cell fluorescence.    
Device 1 
         
Figure 25a                                                    Figure 25b 
Device 2 
         
Figure 25c                                                           Figure 25d 
Device 3 
         
Figure 25e                                                      Figure 25f 
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Control 1 
         
Figure 25g                                                       Figure 25h 
Control 2 
         
Figure 25i                                                          Figure 25j 
Control 3 
         
Figure 25k                                                       Figure 25l 
Figures 25 a-l. Calcein AM live (green) and ethidium homodimer-1 dead (red) cell 
stain results with Design 3, conducted on Day 4 post-cell seeding.   
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4.3.2 Experiment 2   
Viability Stain 
 In another experiment, the HepG2 cells seemingly showed autofluorescence 
in a Day 4 live/dead stain with the Design 3 devices (Figures 26 a–h).  Controls are 
shown in Figures 26 i-n.  
Device 1 
         
Figure 26a                                                     Figure 26b  
 
Device 2 
         
Figure 26c                                                      Figure 26d 
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Device 3 
         
Figure 26e                                                       Figure 26f 
Device 4 
         
Figure 26g                                                     Figure 26h 
Control 1 
         
Figure 26i                                                    Figure 26j 
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Control 2 
         
Figure 26k                                                     Figure 26l 
Control 3 
         
Figure 26m                                                     Figure 26n 
Figures 26 a-n. Fluorescent images of calcein AM live (green) and ethidium 
homodimer-1 dead  (red) cell stain images taken of the Design 3 devices and control 
wells on Day 4 post-cell seeding. 
4.3.3 Experiment 3 
Viability Stain 
 Autofluorescence was observed in both devices and controls (Figures 27 a–p) 
with this live/dead stain conducted on Day 2 after two days of static culture, as with 
the autofluorescence observed in both devices and controls on Day 4 after four days 
of static culture in the previous experiment discussed for Design 3.   The results 
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again indicate that even more brief periods of static culture may still be unsuccessful 
at maintaining cell viability. 
Device 1 
         
Figure 27a                                                     Figure 27b 
Device 2 
         
Figure 27c                                                      Figure 27d 
Device 3 
         
Figure 27e                                                    Figure 27f 
 64 
Device 4 
         
Figure 27g                                                    Figure 27h 
Device 5 
         
Figure 27i                                                        Figure 27j 
Control 1 
         
Figure 27k                                                           Figure 27l 
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Control 2 
         
Figure 27m                                                       Figure 27n 
Control 3 
         
Figure 27o                                                       Figure 27p 
Figures 27 a-p. Day 2 live/dead stain with Design 3 devices and control wells. 
 
4.3.4 Experiment 4  
Viability Stain 
 In this experiment both the Design 3 and Design 4 devices were tested.  
Design 4 devices consisted of the devices bonded to collagen I – coated glass.  
Neither set of devices was visibly more successful than the other at maintaining cell 
viability until Day 2 post-cell seeding (Figures 28 a-e).  Control wells were also not 
consistent in the level of cell viability observed (Figures 28 f-i). 
 
 66 
Design 3 Device 1                                     Design 3 Device 2 
           
Figure 28a                                                     Figure 28b 
 
 
Design 4 Device 1                                     Design 4 Device 2         
         
Figure 28c                                                      Figure 28d 
Design 4 Device 3 
                                            
Figure 28e 
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Control 1                                                     Control 2 
         
Figure 28f                                                     Figure 28g 
Control 3 
         
Figure 28h                                                 Figure 28i 
Figures 28 a-i. Design 4 calcein AM live (green)/ethidium homodimer-1 dead (red) 
cell stain images.  Stain done on Day 2 post-cell seeding. 
4.4 Design 4 – Connected 4-Channel Design 
4.4.1 Experiment 1 
4.4.1.1 Albumin Stain 
 In another experiment, the presence of albumin was indeterminate as 
observed with the fluorescent albumin stain conducted with Design 4 devices and 
controls on Day 2 (Figures 29 a–j).  Note that a rounded area is shown at the end of 
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the channel (Figure 29e); this is due to the image being of the end of one of the 
channels at the rounded junction connecting two channels. 
 One factor in the in the indeterminate presence of albumin may have been 
the short period of time (two days) for which the cells had been in culture. 
 
Albumin Stain  
Device 1 
         
Figure 29a                                                 Figure 29b 
 
Device 2 
         
Figure 29c                                                 Figure 29d 
 
 
 69 
Device 3 
         
Figure 29e                                                   Figure 29f 
Control 1 
         
Figure 29g                                               Figure 29h 
   
Control 2 
 
         
Figure 29i                                               Figure 29j 
Figures 29 a-j. Albumin stain conducted on Design 4 devices and control wells, Day 
2 post-cell seeding. 
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4.4.1.2 Viability Stain 
 The EthD-1 dead cell stain, conducted with the same cells on Day 2 (Figures 
30 a-g), was used to assess the ratio of live to dead cells by counting the total 
number of cells in bright-field images and subtracting the number of dead cells 
stained with EthD-1 to obtain the number of live cells per image. The data show that, 
on average, the mean fraction of live cells was more than half of the cells in the 
devices.  Fractions were not obtained for the control images due to the high number 
of cells in the images.  The data for each device are provided in Table 1.   
        Mean Mean Std. Deviation 
  
Mean 
Total Mean Total Mean # Live/Dead Fraction of of Mean 
Device 
# # Cells 
# Dead 
Cells 
Live 
Cells Ratio Live Cells Fractions 
1 143.5 69.5 74 1.065 0.516 0.196 
2 116.75 27.25 89.5 3.284 0.767   
3 73.5 45.5 28 0.615 0.381   
 
Table 1. Design 4 Experiment 1 - Live/dead cell ratios and mean fraction of live cells 
for each device 
Ethidium Homodimer-1 Dead Cell Stain (red fluorescence) Overlay Images 
Device 1                                                  Device 2 
         
Figure 30a                                                   Figure 30b 
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Device 3                                     
 
Figure 30c 
Control 1 
         
Figure 30d                                              Figure 30e 
Control 2 
         
Figure 30f                                                 Figure 30g 
Figures 30 a-g. Ethidium homodimer-1 stain of cells in Design 4 devices and control 
wells, Day 2 post-cell seeding. 
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4.4.2 Experiment 2 
Albumin Stain 
 
 In another experiment, the devices showed greater levels of albumin by Day 3 
in an albumin stain conducted on the Design 4 devices and controls (Figures 31 a-l).  
Note that rounded areas shown are junctions between channels. 
 The concentration of the antibodies used for the stain had been increased so 
this is a potential reason for the increase in fluorescence from the albumin stain 
between this and the previous experiment. 
Device 1 
         
Figure 31a                                                Figure 31b 
Device 2 
         
Figure 31c                                           Figure 31d 
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Device 3 
         
Figure 31e                                            Figure 31f 
Device 4 
         
Figure 31g                                             Figure 31h 
Control 1 
         
Figure 31i                                                Figure 31j 
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Control 2 
         
Figure 31k                                          Figure 31l 
Figures 31 a-l.  Albumin stain conducted on Design 4 devices and control wells, Day 
3 post-cell seeding. 
4.4.3 Experiment 3 
 In another experiment, an EthD-1 dead cell stain of cells in Design 4 devices, 
conducted on Day 2, showed lower viability than the previous Day 2 EthD-1 stain.  
Note that Device 3 data is not listed in the table, as the device had poor flow of the 
stain through the device, i.e. when the inlet port was filled with the stain (after both 
port volumes had been reduced to a minimum with a pipette), the stain remained in 
the inlet port instead of flowing through the device. 
        Mean Mean 
Std. 
Deviation 
  
Mean 
Total Mean # Mean # Live/Dead Fraction of Mean 
Device 
# # Cells Dead Cells Live Cells Ratio Live Cells Fractions 
1 49.75 34.75 15 0.432 0.302 0.153 
2 17.5 12.25 5.25 0.429 0.300   
4 103.75 45 58.75 1.306 0.566   
3 poor flow           
 
Table 2. Design 4 Experiment 3 - Live/dead ratios and mean fractions of live cells for 
each device 
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 Shown in the figures (Figures 32 a-l) are bright-field and dead cell stain 
images from each device and the control wells. 
Device 1 
         
Figure 32a                                         Figure 32b 
Device 2 
         
Figure 32c                                                Figure 32d 
Device 3 
         
Figure 32e                                               Figure 32f 
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Device 4 
         
Figure 32g                                                 Figure 32h 
Control 1 
         
Figure 32i                                                 Figure 32j 
Control 2 
         
Figure 32k                                                 Figure 32l 
Figures 32 a-l. Ethidium homodimer-1 stain conducted on Design 4 devices and 
controls, Day 2 post-cell seeding.  
  
5 Discussion 
5.1 Experimental Calculations 
 
Surface area to volume ratio, glucose availability to consumption ratio, Reynolds 
number, shear stress, and oxygenation are five factors that affect cell viability and 
expression of hepatocellular function.  Following are the results of calculations of 
these values for the designs tested and discussion of the implications for each 
design. 
 The following surface area-to-volume (SAV) ratios were calculated for each of 
the devices.  The SAV ratios were calculated by dividing the total surface area of the 
top, bottom, and side surfaces in each design by the volume of fluid within the area 
encased by those surfaces. 
 
Design # SAV Ratio 
Design 1 400/cm (100 µm width channel), 
300/cm (200 µm width), 267/cm (300 
µm width), 250/cm (400 µm width) 
Design 2 120/cm 
Design 3 233/cm 
Design 4 159/cm 
Table 3. Device SAV ratios. 
 
The glucose availability to consumption ratios were calculated based on a 
value for HepG2 cell glucose consumption of 10-11 g/cell/h [37] and a glucose 
concentration in HepG2 medium (Eagle’s Modified Essential Medium) of 1 g/L. The 
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Reynolds number for each design was < 1. The amount of shear stress on cells in all 
the devices was estimated at 0.0445 dyn/cm2, using the equation τ = - µ*dv/dz and 
assuming µ = 8.9x10-4; vf= 0.0005 m/s; and zi= 0.0001 m.  This result for shear 
stress may be optimal for the hepatocytes or HPCs, based on data from Tilles and 
colleagues.  Tilles and colleagues showed that at lower wall stresses (0.01 to 0.33 
dyn/cm2), hepatocyte functions, measured as albumin and urea synthesis rates, 
were as much as 2.6- and 1.9- fold greater, respectively, than those at higher wall 
shear stresses (5 to 21 dyn/cm2).[6]  The ratio of oxygen available to oxygen 
consumed in each device was calculated using Equations 2 and 3, where oxygen 
consumption in mols/device/day XO2consumption is calculated from the cell density in the 
microdevice Ncells/cm2, the oxygen consumption of a single hepatocyte per second 
Xonecell=1 x10-16 mols/cell/sec, and the area for the cell culture Sdevice, and where Fmax 
is the amount of oxygen that could be supplied into a device in mols/device/day and 
is estimated from the permeability of oxygen in PDMS DPDMS, the thickness of the 
PDMS wall of the device Δz, and the oxygen concentration gradient across the wall 
of the device ΔC. 
 The constants used in the equations above were an Ncells/cm2  value of 5000 
cells/cm2, an Xonecell value of 10-16 mol/cell/s, a DPDMS value (for 1st, 2nd, and 4th 
designs) of 4.1 x 10-5 cm2/sec, a DH20 value (for 3rd design) of 3.24 x 10-5 
cm2/sec[26], a ΔC = 2 x 10-7 mol O2/cm, and a Δz of 0.3 cm. 
 
5.2 Design 1 
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 We were able to show maintained viability of the adult murine hepatic 
progenitor cells (HPCs) in microchannels (Figures 3-5) until Day 4 post-cell seeding 
with Design 1.  Prior work has not been done with HPCs in microchannels.   
 We were also able to show production of a measurable level of albumin in the 
channels. The albumin production was calculated to be an order of magnitude lower 
(5.55x10-6 ng/cell/h vs. 2.78 x 10-5 ng/cell/h) than that of HPCs cultured in a 
monolayer in a collagen I-coated 35 mm dish. 
 Difficulties with this design included figuring out the best way to load the cells 
into the channels.  The methods used, leaving the dishes flat after adding cells to 
one port and tilting the dishes after cell addition, were not consistently adequate in 
driving cells into the channels.  The cell seeding method might be improved by using 
the method discussed in Materials and Methods Section 3.5.3 of using a cored piece 
of PDMS to plug the inlet port and move the fluid volume towards the channel. 
 Advantages of this design include the simplicity of the design of the one-layer 
microchannel structure, which allows for the elucidation of biological and physical 
responses of cells to the three-dimensional microfluidic environment with a basic 
approach. 
 The MTT assay conducted with a Design 1 device showed an increase in cell 
number with microchannel width with the removal of the data for the 200 µm 
microchannel.  These results do not however suggest that cells are more viable with 
an increase in channel width, as the cell seeding number may have also been 
greater. 
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 The albumin assay conducted with medium collected from Design 1 devices 
on Day 4 with 72 hours of static culture showed an increase in albumin 
concentration with channel width.  Again this increase cannot be attributed to the 
dimensions of the channel, as cell seeding density data was not collected for the 
channels. 
 In another experiment, ELISA data from HPCs in culture for 4 days 
demonstrated a slight increase in albumin secretion with increasing channel width.  
With the same devices, based on a different ELISA experiment, the cells did not 
generate albumin in proportion to the channel width in a 72 hour sample collected at 
Day 7 of the cell culture.  These conflicting results suggest that no correlation can be 
deduced between microchannel width and albumin secretion. 
 Design 1 has the highest SAV ratios (from 400 cm-1 to 250 cm-1) of all the 
devices; a feature which is most conducive to oxygen delivery to the cells.  This 
design, along with Design 4, also has the lowest Reynolds number (Re = 0.056).  A 
lower Reynolds number is conducive to enhanced cell signaling.  The lower flow 
rates that correlate with a lower Reynolds number would prevent cytokines from 
being washed away from a cell’s microenvironment.  With regard to oxygenation, 
Design 1 has the same estimated ratio of oxygen availability to consumption (54.7) 
as Designs 3 and 4 (higher than Design 2) due to the use of the same cell seeding 
density and device thickness values for these devices.  The estimated glucose 
consumption of cells in this device design is also below the glucose availability 
based on the ratio of consumption to availability of 8.33.  In addition, the shear 
stress (0.0445 dyn/cm2) is at or below physiological levels (< 2 dyn/cm2) for the 
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device channel height and the flow rate estimated from observation under the 
microscope. 
5.3 Design 2 
 
 With the Spheroid Chamber design (Figures 6-7) we were able to show that 
HepG2 cells were low in viability after six days in static culture whereas the control 
cell culture was seemingly higher in viability.  As the control seeding density was 
specified, however, and the device seeding density was dependent on the cell 
seeding method, the unknown difference in densities could be a potential reason for 
the difference in viability. 
 In addition to trypan blue viability assays we conducted a calcein 
AM/Ethidium homodimer-1 live/dead viability assay on the cells and observed both 
live (green) and dead (red) fluorescence in both devices and controls in an 
experiment conducted with another cell culture on Day 6 post cell-seeding.  The 
assay was inconclusive at determining the feasibility of a six day static culture at 
maintaining viability, as the level of background in the device and control images 
was similar.   
 In addition to testing the cell culture method we tested cell seeding methods 
and were able to determine that cell injection is more effective than cell settling at 
getting high cell numbers in the device. 
 Advantages of this design include the potential ability, with the proper device 
dimensions, to encase cells or cell aggregates in an environment conducive to cell 
aggregation with the ability to perfuse the cells and handle cells in each culture 
chamber individually.  Current drawbacks include the need to manually core an 
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access port above the culture chamber for cell addition, and the need for relatively 
large dimensions for this access port, for the purpose of pipetting cells into the well, 
in the current design. 
 Design 2 has the lowest SAV ratio (120 cm-1) of all the designs.  In addition, it 
has the highest Reynolds number (0.669).  These characteristics are 
disadvantageous for oxygenation and cell signaling, respectively.  The ratio of 
oxygen availability to consumption (24.0) is also lower since Design 2 has no PDMS 
ceiling, and the diffusion coefficient of oxygen through water is lower than that of 
oxygen through PDMS.  However, one advantage of Design 2 is the ratio of glucose 
available to glucose consumed (250.6) ; because a large volume of medium is 
above the cells in the well, a large amount of glucose is available to the cells relative 
to the amount available in the other designs. 
  
5.4 Design 3 
  
 With the two-layer channel and well design (Figures 8-9) we were able to test 
how cells respond to being cultured in a 300 µm well.  We found that the cells were 
non-viable in Day 4 and Day 2 experiments, based on the amount of background 
observed in live fluorescence images taken after a calcein AM/EthD-1 live/dead cell 
stain.   One possible reason for non-viability is the accumulation in the medium of 
cytokines which inhibited cell survival.  Another is that the cell seeding density is not 
conducive to cell survival.  From observation of the images, cell seeding density was 
lower than in the controls,  As a result of the low cell seeding density, the amount of 
cell aggregation may have also been lower. 
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 An advantage of this design is the ability to observe how cells behave when 
cultured statically in a well below a perfusion channel.  A disadvantage is that the 
design is not conducive to cell settling in a single well in the center of a channel.    
 The SAV ratio (233 cm-1) of Design 3 is lower than those of Design 1 but 
higher than those of Designs 2 and 4, making it relatively advantageous relative to 
Designs 2 and 4.  Its glucose availability to consumption ratio is greater than that of 
Design 4, less than that of Design 2, and similar to that of Design 1, making it 
advantageous primarily relative to Design 4.  Its ratio of oxygen availability to 
consumption (54.7) is the same as Designs 1 and 4 and greater than that of Design 
2, making it advantageous relative to Design 2.  Its Reynolds number (0.112)) is 
greater than that of Designs 1 and 4 and less than that of Design 2, making it 
advantageous for cell signaling relative to Design 2. 
 
5.5 Design 4  
  
 With the fourth design (Figure 10) we showed viability of the HepG2 cells.  In 
addition, we were able to show the presence of some albumin in the channels as 
observed with a fluorescent albumin stain on Day 3 post-cell seeding.  Albumin is an 
indicator of hepatocellular function, therefore this indicates the maintenance of this 
function after seeding of the cells in the microchannels.  The Day 2 albumin stain 
showed indeterminate presence of fluorescence from the albumin.  This may have 
been due to the short period of time in culture and a short amount of time available 
for albumin to reach a measurable amount.  It may have also been due to low 
formation of intracellular contacts which would promote expression of hepatocellular 
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functions such as albumin secretion.  This could be due to a low cell seeding 
density, the structure of the channel, or due to the collagen I ECM coating on the 
bottom surface of the channel.  Thus potential improvements would be to increase 
the seeding density, change the structure of the channel, or test the cell culture 
without an ECM coating or with other ECM coatings.  Viability was shown in the 
channels using EthD-1 stains alone.  In the experiments in which only the EthD-1 
stain was done, the number of live cells in a given image was calculated from the 
total cell count from the bright-field image minus the number of dead cells counted 
from the EthD-1 stain.  The mean ratio of live/dead cells was then calculated for all 
the devices in a given experiment. For both such experiments with this design, the 
number of cells that were alive or dead seemed comparable. 
 
 Advantages of this design include the ability to seed multiple channels with 
the same cell seeding density, the ability to perfuse all the channels at once, and the 
simplicity of the microchannel design, as with Design 1, which allows for a more 
basic elucidation of cellular responses to the microchannel environment.  
Disadvantages include the lack of a method to prevent cells from washing out of the 
channel. 
 Design 4 has an SAV ratio (159 cm-1) higher than Design 2 but lower than 
Designs 1 and 3, making it advantageous for oxygenation only relative to Design 2.  
Its glucose availability (availability to consumption ratio of 5.26) is the lowest of all 
the devices, making it disadvantageous in this parameter.  Its Reynolds number 
(0.056) is the same as that of Design 1, making it advantageous for cell signaling, 
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while its oxygenation ratio (54.7) is also the same as Designs 1 and 3 and higher 
than Design 2, making it advantageous for oxygenation relative to Design 2. 
 We were able to show that both HPCs and HepG2 cells can be kept viable 
and express hepatocellular function in microfluidic environments, in devices based 
on designs 1 (HPC cell cultures) and designs 2 through 4 (HepG2 cell cultures).  
 The physical phenomena of the microscale may allow for a more in vivo-like 
environment for cell culture and the culture of more in vivo-like liver tissue for 
transplantation, extracorporeal therapy, drug screening, biological studies, and other 
applications.  Here we have studied the effects of placing hepatic progenitor cells 
and HepG2 cells in microfluidic devices, and shown that the cells do survive and 
express the hepatocellular function of albumin secretion.  This research may assist 
in future studies with microfluidic in vitro liver cell cultures through having helped 
answer some basic biological questions and test various methods of operating the 
microfluidic devices. 
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